Trial of Acupuncture for Reduction of Post-Colectomy Ileus
A Phase II Randomized Controlled Trial of Acupuncture for Reduction of Post-Colectomy Ileus
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of this study is to see whether acupuncture may help patients recover from colon cancer surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Oct 2006
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 22, 2006
CompletedFirst Posted
Study publicly available on registry
November 23, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedOctober 12, 2015
October 1, 2015
6.3 years
November 22, 2006
October 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine whether a Phase III trial of acupuncture for postoperative recovery after colorectal surgery is warranted as defined by evidence of reduction of postoperative ileus when compared to sham acupuncture
end of study
Secondary Outcomes (7)
To explore whether acupuncture improves patient satisfaction with the hospital experience by ameliorating other postoperative symptoms such as pain and nausea and vomiting
daily pain score, opioids consumption (total dose of morphine equivalent during hospitalization and average dose per day) severity of nausea as defined by number of request for PRNantiemetics, and number of emetic episodes during hospital stay.
To determine the feasibility of a Phase III trial in terms of sample size, accrual rate, attrition rate and data completion
end of study
GI-2, (also representing time to recovery of gastrointestinal [GI] function)
patient first tolerated solid food,and time patient first passed a bowel movement
GI contractions measured with a multifunctional stethoscope
duration of two minute before and immediately after each true or sham acupuncture treatment.
Daily pain score
daily during hospitalization
- +2 more secondary outcomes
Study Arms (2)
1
ACTIVE COMPARATORAcupuncture is the insertion of needles at certain body points.
2
SHAM COMPARATORsham acupuncture
Interventions
Acupuncture will be given twice daily for a total of three days (Day 1 to 3). The two acupuncture sessions will be separated by at least 4 hours, preferably given in the morning and late afternoon. Each session will last approximately 30 minutes, starting from the moment the first needle is inserted and ending the moment the first needle is removed. The last treatment will be given at the end of Day 3 or day of discharge.
Sham Acupuncture involves the acupuncturist tapping a plastic guiding tube on the surface of the true points to produce some discernible sensation and then immediately tapping a real needle sideways parallel to the skin surface without needle insertion. It will be given twice daily for a total of three days (Day 1 to 3). The two acupuncture sessions will be separated by at least 4 hours, preferably given in the morning and late afternoon. Each session will last approximately 30 minutes, starting from the moment the first needle is inserted and ending the moment the first needle is removed. The last treatment will be given at the end of Day 3 or day of discharge,
Eligibility Criteria
You may qualify if:
- Men or women of any ethnicity
- Age over 18 years (children are not included because colorectal cancer is rare in children).
- Scheduled to undergo elective resection of biopsy proven colorectal cancer or suspected colorectal cancer
You may not qualify if:
- Pre-operative factors:
- History of major abdominal or pelvic surgery that have caused significant alteration in anatomy and function of the GI tract which may affect the endpoints of this study.
- Laparoscopic procedures. They tend to result in less postoperative ileus.
- Administration of epidural anesthetics or epidural opioids: these have previously been shown to affect postoperative GI motility. They made up only 5% of colectomy patients in the investigators' institution.
- Acupuncture within the last 4 weeks (to exclude any possible residual effect from acupuncture)
- Contraindications to use of electrical stimulation, including cardiac pacemaker and implantable cardioverter defibrillator (ICD)
- Prior serious adverse event with acupuncture
- Intra-operative events (these events alter the postoperative recovery course significantly):
- Resection incorporating the upper GI tract. Such surgeries are usually more complex, involving more organs and are associated with a more diverse postoperative course, making the study population more heterogeneous.
- Gross fecal spillage (high complication rate in this setting)
- Need to leave nasogastric tube in (contaminating the primary endpoint)
- Decision to give epidural anesthetics or epidural opioids postoperatively (shown previously to change the major endpoints)
- Complications during surgery requiring a patient to be transferred to the Intensive Care Unit (ICU) directly from the Operating Room or Post Anesthesia Care Unit (PACU) as this also alters the postoperative course significantly. Patients transferred to the floor first will not be excluded. They will be fully registered and randomized. If they deteriorate later during the hospital stay, requiring a transfer to the ICU, they will still be followed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan-Kettering Cancer Center 1275 York Avenue
New York, New York, 10021, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary Deng, MD, PhD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2006
First Posted
November 23, 2006
Study Start
October 1, 2006
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
October 12, 2015
Record last verified: 2015-10